Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News Analysis
Nature Reviews Drug Discovery 6, 267–268 (1 April 2007) | doi:10.1038/nrd2295
Telbivudine
&
Abstract
Telbivudine (Tyzeka; Idenix/Novartis), a nucleoside analogue that inhibits the hepatitis B virus polymerase, was approved by the US FDA in October 2006 for the treatment of adults with chronic hepatitis B.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
